CDC Panel Recommends Pfizer COVID Boosters for Ages 12-15
The 13-1 vote follows FDA approval for a booster dose in that age group on Monday. The committee backed a “should” rather than a “may” recommendation for ages 12-15 and for ages 16-17 as well.
Landwebs
0
7
The 13-1 vote follows FDA approval for a booster dose in that age group on Monday. The committee backed a “should” rather than a “may” recommendation for ages 12-15 and for ages 16-17 as well.
